---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-051513"
form_type: "8-K"
ticker: "HYPR"
cik: "0001833769"
company_name: "Hyperfine, Inc."
filed_at: "2023-10-03T23:59:59+00:00"
generated_at: "2026-06-10T05:37:27.196166+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Hyperfine terminates CMO/CSO Khan Siddiqui; transitions to consultant

## Summary
- Khan Siddiqui terminated as Chief Medical Officer and Chief Strategy Officer effective September 30, 2023.
- Will continue as consultant at $300/hour; salary paid through separation date.
- Outstanding equity awards to continue vesting during consulting period under 2021 Equity Plan.
- Separation agreement includes $500 payment, standard release, and non-disparagement.
- No replacement named for the dual roles.

## SEC filing metadata
- accession: 0000950170-23-051513
- form_type: 8-K
- ticker: HYPR
- cik: 0001833769
- company_name: Hyperfine, Inc.
- filed_at: 2023-10-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1833769/000095017023051513/0000950170-23-051513-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1833769/000095017023051513/hypr-20230927.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-051513
- JSON: https://secwatch.observer/filing/0000950170-23-051513.json
- Plain text: https://secwatch.observer/filing/0000950170-23-051513.txt

## Key facts
- Executive change
  Khan Siddiqui was terminated as Chief Medical Officer and Chief Strategy Officer at Hyperfine, Inc..
  - Action: terminated
  - Role: Chief Medical Officer and Chief Strategy Officer
  source text: On September 27, 2023, Hyperfine, Inc. (the “Company”) terminated Khan Siddiqui, M.D.’s part-time employment as the Company’s Chief Medical Officer and Chief Strategy Officer, effective September 30, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1833769/000095017023051513/0000950170-23-051513-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.